UCSF

Faculty 2013–2014 Cycle 6

San Francisco, CA

The American Course on Drug Development and Regulatory Sciences (ACDRS) teaching faculty are science-driven and highly experienced international faculty members with a network of experts in pharmaceutical medicine, medical product development, and regulatory sciences.

Name Affiliation Location
Enrica Alteri, MD European Medicines Agency (EMA) London, United Kingdom
Deborah Arrindell, MD, MPH, JD Amgen Thousand Oaks, CA
Scott Berry, PhD Berry Consultants Austin, TX
Bruce S. Binkowitz, PhD Merck and Co., Inc. Rahway, NJ
D. Bruce Burlington, MD Independent Consultant Washington, DC
Joseph Caminiti BQ6 Media Group, LLC Horsham, PA
Louis R. Cantilena, MD, PhD Medical Strategic Initiatives, LLC Bethesda, MD
John Celona, JD Stanford University Medical Center Stanford, CA
Dale Cooke Digitas Health Philadelphia, PA
Dinesh de Alwis, PhD Merck and Co., Inc. North Wales, PA
Manoj Desai, PhD Gilead Foster City, CA
MJ Edwards, JD Gilead Foster City, CA
Patricia Evans, PhD Independent Consultant San Francisco, CA
David W. Feigal, Jr, MD, MPH Arizona State University School of Law Tempe, AZ
Becki Filice, MBA Achaogen South San Francisco, CA
Leslie C. Floren, PharmD University of California, San Francisco San Francisco, CA
Joshua Galanter, MD University of California, San Francisco San Francisco, CA
Brenda L. Gaydos, PhD Eli Lilly and Company Indianapolis, IN
Charles T. Gombar, PhD Endo Chadds Ford, PA
Charles Grudzinskas, PhD NDA Partners, LLC Annapolis, MD
Christopher Horvath, DVM, MS, DACVP INTICA Biomedical, Inc. Cambridge, MA
Florence Houn, MD, MPH, FACP Celgene Washington, DC
John Jenkins, MD Food and Drug Administration (FDA) Silver Spring, MD
Qi Jiang, PhD Amgen Thousand Oaks, CA
Diane K. Jorkasky, MD, FACP Independent Consultant Philadelphia, PA
Kenneth Kaitin, PhD Tufts University Boston, MA
Jerry N. Karabelas, PhD Care Capital Princeton, NJ
Sara Kenkare-Mitra, PhD Genentech South San Francisco, CA
Richard L. Lalonde, PharmD Pfizer New London, CT
Siu Ping Lam, PhD, BPharm, FRPharmS, MTOPRA Medicines Health products Regulatory Agency (MHRA) London, United Kingdom
Zili Li, MD, MPH Bill & Melinda Gates Foundation Beijing, China
Uri Lopatin, MD Assembly Pharmaceuticals San Francisco, CA
Murray M. Lumpkin, MD, MSc Food and Drug Administration (FDA) Silver Spring, MD
Kathleen B. Meyer-Tamaki, MPH, PhD, DABT Nonclinical Consulting Services San Francisco, CA
Diane R. Mould, PhD, FCP Projections Research Inc. Philadelphia, PA
Bernard Munos, MBA InnoThink Center for Research in Biomedical Innovation Indianapolis, IN
Mark Noguchi, MBA Roche South San Francisco, CA
Kourosh Parivar, PhD Pfizer San Diego, CA
Carl C. Peck, MD University of California, San Francisco San Francisco, CA
J. Robert Powell, PharmD Roche Shanghai, China
Malcolm Rowland, PhD, DSc University of California, San Francisco United Kingdom
Stephen J. Ruberg, PhD Eli Lilly and Company Indianapolis, IN
Mario Saltarelli, MD Shire Wayne, PA
Frank Sasinowski, JD, MS, MPH Hyman, Phelps & McNamara PC Washington, DC
David Savello, PhD Xenoport Santa Clara, CA
Brian Smith, PhD Amgen Thousand Oaks, CA
Steven M. Snapinn, PhD Amgen Thousand Oaks, CA
Catherine Angell Sohn, PharmD, CLP Sohn Health Strategies, LLC Voorhees, NJ
Dominic G. Spinella, PhD Biodesix, Inc Boulder, CO
S. Aubrey Stoch, MD Merck and Co., Inc. Rahway, NY
Mason Tenaglia, MBA Amundsen Consulting Burlington, MA
Toshiyoshi Tominaga, PhD Osaka City University Osaka, Japan
Peter Virsik, MBA, MS Xenoport Santa Clara, CA
Russell Wada, PhD Quantitative Solutions San Francisco, CA
Laurene Wang-Smith, PhD NDAPharma Raleigh-Durham, NC
David Wustrow, PhD Cleave Biosciences Burlingame, CA
Gary Yeung, CFA Genentech South San Francisco, CA
Martin J. Zagari, MD Amgen Thousand Oaks, CA
Michael G. Zager, PhD Pfizer San Diego, CA

Faculty in other years

See Faculty.